Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Musculoskeletal | Immunology | Family Medicine
Disease Category: Rheumatoid Arthritis
Location: United States, AR
If you have RA and have had an inadequate response to a TNF-a inhibitor, contact us today!
The purpose of this research study is to find out the effectiveness and safety of 2 different doses of a new study drug in subjects with RA who have had an inadequate response to a TNF-a inhibitor.
Patient Inclusion Criteria:
- Males or females =18 years of age.
- Diagnosis of adult-onset RA of at least 6 months
- Patients must have been treated at approved doses with at least one biologic TNF-a inhibitor therapy
- Regular use of at least one conventional DMARD
- Women must not be pregnant, breastfeeding, or at risk to become pregnant during study participation.
Patient Exclusion Criteria:
- Have had surgical treatment within 60 days of a joint that is to be assessed in the study or will require such treatment during the study.
- Have had any major surgery within 60 days, or will require such during the study.
- Have active fibromyalgia or have a diagnosis of any systemic inflammatory condition other than RA
- Have had any malignancy within the past 5 years, except for cervical carcinoma in situ that has been resected with no evidence of recurrence or metastatic disease, or basal cell or squamous epithelial skin cancers that were completely resected and have no evidence of recurrence for at least three years.
- Are positive for human immunodeficiency virus (HIV).
- Have had a serious infection (e.g., pneumonia, cellulitis) within 3 months of baselineor had serious bone or joint infections within 6 months
- Have an active or recent infection (including symptomatic herpes zoster or herpes simplex) within 30 days
- Have evidence of active or latent tuberculosis (TB) as documented by a positive PPD test
Paul Koros, RN, Site Manager
NEA Baptist Clinic - Clinical Research Center
416 E. Washington, Suite C
Jonesboro, AR 72401
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these